Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Alzheimer’s disease

New biomarkers for early-stage tau pathology in Alzheimer’s disease

Current diagnostic approaches lack sensitivity for the early-stage tau changes that precede neurofibrillary tangles in Alzheimer’s disease. Islam, Hill, Abrahamson and colleagues identify phospho-tau Ser262 and Ser356 as potential biomarkers for early-stage tau aggregation in Alzheimer’s disease. These findings could revolutionize the early diagnosis of and therapeutic strategies for Alzheimer’s disease, which offers hope for more effective interventions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Schematic of p-tau Ser262 and Ser356 as biomarkers for early tau aggregation in Alzheimer’s disease.

References

  1. Self, W. K. & Holtzman, D. M. Nat. Med. 29, 2187–2199 (2023).

    Article  CAS  PubMed  Google Scholar 

  2. Chang, C. W., Shao, E. & Mucke, L. Science 371, eabb8255 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Otero-Garcia, M. et al. Neuron 110, 2929–2948 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Livingston, G. et al. Lancet 390, 2673–2734 (2017).

    Article  PubMed  Google Scholar 

  5. Jack, C. R. Jr. et al. Alzheimers Dement. 20, 5143–5169 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Jiang, Y. et al. Alzheimers Dement. 20, 2000–2015 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Islam, T. et al. Nat. Med. 31, 574–588 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ossenkoppele, R., van der Kant, R. & Hansson, O. Lancet Neurol. 21, 726–734 (2022).

    Article  CAS  PubMed  Google Scholar 

  9. Ariza, M., Kolb, H. C., Moechars, D., Rombouts, F. & Andrés, J. I. J. Med. Chem. 58, 4365–4382 (2015).

    Article  CAS  PubMed  Google Scholar 

  10. Macedo, A. C. et al. J. Nucl. Med. 64, 1171–1178 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Leuzy, A. et al. Mol. Psychiatry 24, 1112–1134 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chatterjee, M. et al. Nat. Med. 30, 1771–1783 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tracy, T. E. et al. Cell 185, 712–728 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Chu, Y. et al. Brain 147, 444–457 (2024).

    Article  PubMed  Google Scholar 

  15. Xiang, J. et al. Neuron 112, 3585–3601 (2024).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Y. Yang for her assistance with drawing the figure. The authors were supported by the National Natural Science Foundation of China (grants 82471445 and 32170988 to R.L.), and a grant from the Startup Foundation for Introducing Talent of Lanzhou University (grant 561120215 to R.L.).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Rongcan Luo or Jin-Tai Yu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, R., Yu, JT. New biomarkers for early-stage tau pathology in Alzheimer’s disease. Nat Aging 5, 734–735 (2025). https://doi.org/10.1038/s43587-025-00854-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43587-025-00854-w

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing